The Biotechnology Center of Excellence Corporation (BCEC) provides technical assistance and public policy guidance in biotechnology development to public agencies and universities in the U.S. and abroad. It maintains cooperative agreements for technology transfer projects in health care, agriculture, and environmental protection with several entities. These include the Northern Regions Center of Hokkaido, Japan; the Quebec Biotechnology Innovation Center in Laval,Quebec,Canada; the University of Ulster in Northern Ireland, UK; the Consortium for the Development of the Industrial Area of Cagliari, Consortium 21 in Sardinia, Italy; the Zamudio Technology Park near Bilbao, Spain; and Binghampton University in New York. Former collaborations include agreements with the United Nations Industrial Development Organization in Vienna, Austria,the BioMinas Foundation in Minas Gerais, Brazil; the Fundación Chile in Santiago, Chile; the Queensland Government Office in Los Angeles and Uniquest of Queensland, Australia.
BioAmericas. Through its BioAmericas program, BCEC advises government agencies and universities in Chile in the area of biotechnology development policy for agriculture and related areas. BCEC has also completed a major study for the Corporacion Andina de Fomento in Caracas, Venezuela available at www.caf.com entitled "Biotecnologia para el Desarrollo Sostenible de la Biodiversidad". This study relates to global markets for biodiversity-based resources in Bolivia, Colombia, Ecuador, Peru and Venezuela. BCEC staff is also engaged with the United Nations Economic Commission for Latin America and the Carribean (www.eclac.cl) in providing strategic policy guidelines for biodiversity usage and biotechnology development in the Andean region and elswhere in Latin America. In the marine biotechnology area, BCEC served as the founding Secretariat for the Pan American Marine Biotechnology Association.
A private non-profit organization since 1991, BCEC is a successor agency of the Massachusetts Centers of Excellence Corporation, created by the Commonwealth of Massachusetts in 1985 to facilitate technology transfer and commercialization of emerging technologies through university/industry collaboration. In this capacity, its support enabled the establishment of the Massachusetts Biotechnology Research Institute, now the Massachusetts Biomedical Initiatives (MBI) in Worcester, MA., providing the initial administrative funds to set up the incubation and venture capital instruments originally associated with that effort.